Rephonic
Artwork for COR2ED

COR2ED - Oncology Medical Conversation

COR2ED Medical Education
Neuroendocrine Tumors
Prostate Cancer
Colorectal Cancer
Biomarker Testing
Non-Small Cell Lung Cancer
Precision Medicine
Targeted Therapy
Ovarian Cancer
Biomarkers
Lung Cancer
Immunotherapy
Germline Mutations
Next-Generation Sequencing
BRAF V600E Mutation
HER2
CNS Metastasis
Intermediate Hepatocellular Carcinoma
Clinical Trials
Targeted Therapies
PARP Inhibitors

Join oncology experts as they discuss their approaches to diagnosing and managing patients with gastrointestinal, genitourinary, lung, breast, gynecological, neuroendocrine and hematological cancers, sarcomas, and more. The conversations also explore cutting edge developments in precision oncology, as well as emerging treatments, including immunotherapy. This independent medical education podcast ... more

PublishesInfrequentlyEpisodes92Founded3 years ago
Categories
CoursesEducationScience

Listen to this Podcast

Artwork for COR2ED

Latest Episodes

Pre-analytical Phase Challenges and Biomarker Testing in HER2+ Metastatic Breast Cancer

Key clinical takeaways:

• Metastatic breast cancer (mBC) is a complex, heterogeneous disease requiring multidisciplinary collaboration. Pathologists are central... more

Understanding HER2-low and HER2-ultralow classification in mBC

In this video podcast moderated by the Oncology Brothers, Dr Komal Jhaveri provides a practical overview of how this shift beyond a binary HER2 model translates into everyday clinical pr... more

In this podcast, Medical Oncologist, Dr Aman Chauhan and Neuroendocrine Patient Advocate, Susan Meckler-Plummer, discuss extrapulmonary high-grade neuroendocrine carcinomas (EP-NECs), a rare, aggressive, and often misunderstood subset of neuroendocri... more

How are advances in radioligand therapy shaping the treatment of neuroendocrine tumours, and what does recent trial evidence tell us? What are the key considerations for patient selection, sequencing, and safety?

In this podcast moderated by the Onc... more

Metastatic pancreatic ductal adenocarcinoma (mPDAC) is notoriously aggressive with a poor prognosis. It is often diagnosed late, and by this time, surgery is usually not an option. Median overall survival without treatment is just a few months but wi... more

YouTube

Listen to a revealing conversation between Dr Joshua Sabari, a Medical Oncologist specialising in the treatment of rare alternations of NSCLC and Debra Montague, President of Lung Cancer Europe (LuCE) and founder of ALK Positive UK.

As a patient adv... more

Episode 2: Navigating common treatment scenarios in HER2-mutant NSCLC

This is the second episode of a two-part series on the HER2 diagnostic and treatment landscape in NSCLC, hosted by the Oncology Brothers, Drs Rohit and Rahul Gosain.

In this epis... more

YouTube

Episode 1: Identifying HER2-directed NSCLC: The Medical Oncologist and Pathologist perspectives

This is the first episode of a two-part series on the HER2 diagnostic and treatment landscape in NSCLC, hosted by the Oncology Brothers, Drs Rohit and Ra... more

YouTube

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host

Similar Podcasts

People also subscribe to these shows.

Global News Podcast
Global News PodcastBBC World Service

Recent Guests

Susan Meckler-Plummer
A nurse with extensive experience working with neuroendocrine carcinoma patients since her husband's diagnosis in 2013.
Episode: Understanding EP-NEC: Through Diagnosis, Treatment, and Support
Heloisa Soares
A medical oncologist focusing on neuroendocrine tumors
Episode: Exploring the role of targeted radiopharmaceutical treatment in NETs
Ken Herrmann
A nuclear medicine physician from Europe
Episode: Exploring the role of targeted radiopharmaceutical treatment in NETs
Isabel Preeshagul
Thoracic Medical Oncologist at Memorial Sloan Kettering
Memorial Sloan Kettering
Episode: The HER2 diagnostic and treatment landscape in NSCLC
Eric Singhi
Thoracic Medical Oncologist at MD Anderson Cancer Center
MD Anderson Cancer Center
Episode: The HER2 diagnostic and treatment landscape in NSCLC
Fernando Lopéz-Ríos
Pathologist from Madrid, Spain
Episode: The HER2 Diagnostic and Treatment Landscape in NSCLC
Devika Das
Thoracic medical oncologist from the University of Florida Health
University of Florida Health
Episode: The HER2 Diagnostic and Treatment Landscape in NSCLC
Dr. Lorenza Rimassa
Medical oncologist and head of Hippado-Iliari Cancer Program
Hippado-Iliari Cancer Program, Milan, Italy
Episode: HCC podcast series part 2: 2nd line treatment in advanced HCC and when to switch
Dr. Arndt Vogel
Hepatologist and medical oncologist
Toronto, Canada
Episode: HCC podcast series part 2: 2nd line treatment in advanced HCC and when to switch

Hosts

Aman
Host discussing high-grade neuroendocrine carcinomas.
Rohit Gosain
Co-host of the Oncology Brothers podcast,
Rahul Gosain
Co-host of the Oncology Brothers podcast,

Top Science Podcasts

Something You Should Know
Something You Should KnowMike Carruthers | OmniCast Media
Hidden Brain
Hidden BrainHidden Brain, Shankar Vedantam
Radiolab
RadiolabWNYC Studios
Health Optimization Medicine Podcast
Health Optimization Medicine PodcastHealth Optimization Medicine and Practice
StarTalk Radio
StarTalk RadioNeil deGrasse Tyson
Big Ideas Lab
Big Ideas LabMission.org
Science Friday
Science FridayScience Friday and WNYC Studios
Are We Doomed?
Are We Doomed?NPR Network
Science Vs
Science VsSpotify Studios

Talking Points

Recent interactions between the hosts and their guests.

Understanding Rare NSCLC Mutations: Insights, access and support
Q: How did that discussion go with your clinician regarding these newer targeted therapies?
Debra had a supportive oncologist who was honest about her knowledge of ALK mutations and was open to finding information, guiding her toward a targeted therapy rather than chemotherapy.
Understanding Rare NSCLC Mutations: Insights, access and support
Q: Can you tell me how these rare mutations are actually identified?
These mutations are generally identified through broad panel next generation sequencing, ideally done at diagnosis, to inform treatment options.
Câncer de Próstata: Desafios da Fase Pré-Analítica e Teste de Biomarcadores
Q: When do you test these patients on progression or rely on what the NGS was on the prior specimen?
Testing should ideally trigger upon treatment progression, particularly during castration-resistant prostate cancer stages.
Câncer de Próstata: Desafios da Fase Pré-Analítica e Teste de Biomarcadores
Q: What challenges are commonly experienced in prostate cancer biomarker testing that impacts the quality of these results?
Key challenges include accessing adequate tissue for testing and the variability in tissue quality impacting test results.
Câncer de Próstata: Desafios da Fase Pré-Analítica e Teste de Biomarcadores
Q: What are the various biomarkers in prostate cancer we should test for and what tests can be used for this information?
There is a lot of data around biomarkers in prostate cancer, including DNA repair gene alterations and MSI high status for treatment selection.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About COR2ED

What is COR2ED about and what kind of topics does it cover?

This show features in-depth discussions with oncology clinicians, researchers, and medical experts about diagnosing and managing a wide range of cancers, with a strong emphasis on precision oncology, cutting-edge therapies, and real-world patient care. Episodes frequently explore treatment paradigms, diagnostic testing, clinical trial data, and multidisciplinary approaches, often featuring patient advocates or health-system professionals who share insights into gaps and opportunities in care delivery. A notable pattern is the mix of clinical focus (specific cancers, biomarkers, targeted therapies) with practical takeaways for healthcare professionals and researchers, making it a valuable resource for staying current on emerging treatments a... more

Where can I find podcast stats for COR2ED?

Rephonic provides a wide range of podcast stats for COR2ED. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to COR2ED and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does COR2ED get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for COR2ED, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for COR2ED?

Rephonic provides comprehensive predictive audience data for COR2ED, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does COR2ED have?

To see how many followers or subscribers COR2ED has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to COR2ED?

These podcasts share a similar audience with COR2ED:

1. Global News Podcast

How many episodes of COR2ED are there?

COR2ED launched 3 years ago and published 92 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact COR2ED?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for COR2ED?

Rephonic pulls ratings and reviews for COR2ED from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for COR2ED?

Rephonic provides full transcripts for episodes of COR2ED. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on COR2ED?

Recent guests on COR2ED include:

1. Susan Meckler-Plummer
2. Heloisa Soares
3. Ken Herrmann
4. Isabel Preeshagul
5. Eric Singhi
6. Fernando Lopéz-Ríos
7. Devika Das
8. Dr. Lorenza Rimassa

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days